About
Kirkpatrick has over 25 years of experience managing venture investments and technology development programs across oncology, inflammation, metabolic disease, neurological disorders, and biotherapeutics and life science tools. He oversees RCT's venture investments, technology development, and special licensing programs, and serves on several biomedical startup boards, including as a founding director of the Critical Path Institute.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Alimmune LLCAPT Pharmaceuticals Inc.AustinPx™, LLCCodis™Cylene Pharmaceuticals Inc.Imagine Pharmaceuticals Inc.Pheon TherapeuticsProlifia Inc.Sertoli Technologies, Inc.Therapeutic Human Polyclonals Inc.Translational Drug Development, LLC
Per the firm's website.
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Brad Morie
Senior Director, Biotechnologies at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies